Haemonetics Corporation

Haemonetics Corporation Misses on EPS, Stock Down 4.54%

Haemonetics Corporation reported an EPS of $0.72, which was below expectations, leading to a stock decline of 4.54%. The lack of revenue figures and management commentary adds uncertainty for investors. Overall, the earnings miss may raise concerns about the company's performance in the near term.